SZSE:300254 (China)
Â
Class A
Â¥
8.53
(-0.12%)
Jun 20
Shanxi C&Y Pharmaceutical Group Co Ltd Valuation Measures
Fundamental (48)
Valuation Ratio (77)
Profitability (7)
Price (14)
Dividends (7)
Income Statement (47)
Balance Sheet (83)
Cashflow statement (66)